Home Markets Regeneron to defend against DOJ complaint on drug-price manipulation

Regeneron to defend against DOJ complaint on drug-price manipulation

Apr 16, 2024 comments off

Original source: https://www.investing.com/news/stock-market-news/regeneron-to-defend-us-justice-departments-complaint-on-drugpricing-manipulation-3379239

You May Also Like

Lynas signs rare earth supply pact with US Department of War

JD.com launches Joybuy in Europe, targeting Amazon

Perpetual to sell wealth management arm to Bain Capital for $350 million upfront

Walmart, Target outpace peers in AI-driven supply chain race, Jefferies says

Booking, Expedia face margin pressure from AI agents, Bernstein says

Goldman: Software giants face ‘radical transformation’ as agentic AI rises